SAR402663

· Sanofi

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SAR402663, covering 2025-11-21 to 2025-11-21. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Efficacy Study of One-time SAR402663 in Adults With Neovascular Age-related Macular Degeneration [Phase 1, Phase 2]

See pricing